Emma Reeve insider trades: Ptc Therapeutics (PTCT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Emma reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | PTCT | ↓ Sell | 734 | $76.00 | $56K | Direct | Jan 6, 2026 (1d) |
| Dec 3, 2025 | PTCT | ↓ Sell | 733 | $78.62 | $58K | Direct | Dec 5, 2025 (2d) |
| Nov 21, 2025 | PTCT | ↓ Sell | 10,000 | $79.50 | $795K | Direct | Nov 25, 2025 (4d) |
| Nov 12, 2025 | PTCT | ↓ Sell | 7,333 | $74.50 | $546K | Direct | Nov 14, 2025 (2d) |
| Oct 30, 2025 | PTCT | ↓ Sell | 15,666 | $69.50 | $1.1M | Direct | Oct 31, 2025 (1d) |
| Oct 3, 2025 | PTCT | ↓ Sell | 25,562 | $65.96 | $1.7M | Direct | Oct 7, 2025 (4d) |
| Sep 11, 2025 | PTCT | ↓ Sell | 15,705 | $59.50 | $934K | Direct | Sep 16, 2025 (5d) |
| May 23, 2023 | PTCT | ↓ Sell | 9,768 | $59.53 | $582K | Direct | May 24, 2023 (1d) |
| Apr 21, 2023 | PTCT | ↓ Sell | 4,328 | $55.05 | $238K | Direct | Apr 25, 2023 (4d) |
| Feb 22, 2021 | CNST | ↓ Sell | 10,270 | $37.64 | $387K | Direct | Feb 23, 2021 (1d) |
| Feb 18, 2021 | CNST | ↓ Sell | 1,510 | $37.58 | $57K | Direct | Feb 19, 2021 (1d) |
| Dec 21, 2020 | CNST | ↓ Sell | 5,720 | $35.11 | $201K | Direct | Dec 22, 2020 (1d) |
| Dec 14, 2020 | PTCT | ↓ Sell | 1,972 | $68.00 | $134K | Direct | Dec 16, 2020 (2d) |
| Jun 8, 2020 | CNST | ↓ Sell | 589 | $37.55 | $22K | Direct | Jun 10, 2020 (2d) |
| May 11, 2020 | CNST | ↓ Sell | 28,803 | $49.53 | $1.4M | Direct | May 12, 2020 (1d) |
| Apr 17, 2020 | CNST | ↓ Sell | 760 | $35.29 | $27K | Direct | Apr 20, 2020 (3d) |
| Apr 14, 2020 | CNST | ↓ Sell | 1,225 | $35.20 | $43K | Direct | Apr 16, 2020 (2d) |
| Apr 9, 2020 | CNST | ↓ Sell | 700 | $35.02 | $25K | Direct | Apr 13, 2020 (4d) |
| Feb 13, 2020 | CNST | ↓ Sell | 6,624 | $35.05 | $232K | Direct | Feb 14, 2020 (1d) |
| Feb 11, 2020 | CNST | ↓ Sell | 8,842 | $35.04 | $310K | Direct | Feb 12, 2020 (1d) |
| Nov 6, 2019 | CNST | ↓ Sell | 65,626 | $21.50 | $1.4M | Direct | Nov 8, 2019 (2d) |
| Nov 5, 2019 | CNST | ↓ Sell | 1,000 | $15.50 | $16K | Direct | Nov 7, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PTCT insiders
Open-market trades in the last 12 months
About Emma Reeve's insider trades
Emma Reeve is an insider at Ptc Therapeutics (PTCT). Since Nov 5, 2019, Emma has reported no open-market purchases and 22 sales worth $10.3M on SEC Form 4. In the last 12 months: 4 sales ($1.5M).
Their filings also include grants and awards (24 filings), option exercises (21 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.